{
    "text": "The use of the methylation status of P16, RASSF1A, APC, RAR\u03b2, DAPK, CDH13, and MGMT could become a promising and powerful biomarker for the detection and screening of NSCLC in blood in clinical settings.", 
    "denotations": [
        {
            "id": "T1", 
            "obj": "P16", 
            "span": {
                "begin": 37, 
                "end": 40
            }
        }, 
        {
            "id": "T1", 
            "obj": "RASSF1A", 
            "span": {
                "begin": 42, 
                "end": 49
            }
        }, 
        {
            "id": "T1", 
            "obj": "APC", 
            "span": {
                "begin": 51, 
                "end": 54
            }
        }, 
        {
            "id": "T1", 
            "obj": "RAR\u03b2", 
            "span": {
                "begin": 56, 
                "end": 61
            }
        }, 
        {
            "id": "T1", 
            "obj": "DAPK", 
            "span": {
                "begin": 63, 
                "end": 67
            }
        }, 
        {
            "id": "T1", 
            "obj": "CDH13", 
            "span": {
                "begin": 69, 
                "end": 74
            }
        }, 
        {
            "id": "T1", 
            "obj": "MGMT", 
            "span": {
                "begin": 80, 
                "end": 84
            }
        }, 
        {
            "id": "T1", 
            "obj": "NSCLC", 
            "span": {
                "begin": 168, 
                "end": 173
            }
        }
    ],
    "relations": [
        {
            "id":"R1",
            "pred":"causes",
            "subj":"T2", 
          "obj":"T1"}
    ]
}